Title : Avanafil for erectile dysfunction.

Pub. Date : 2013 Oct

PMID : 24259695






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 DATA SYNTHESIS: Avanafil is a highly selective PDE5 inhibitor that is a competitive antagonist of cyclic guanosine monophosphate. avanafil phosphodiesterase 5A Homo sapiens
2 Specifically, avanafil has a high ratio of inhibiting PDE5 as compared with other PDE subtypes allowing for the drug to be used for ED while minimizing adverse effects. avanafil phosphodiesterase 5A Homo sapiens
3 A network meta-analysis comparing the PDE5 inhibitors revealed avanafil was less effective on Global Assessment Questionnaire question 1 while safety data indicated no major differences among the different PDE5 inhibitors. avanafil phosphodiesterase 5A Homo sapiens
4 CONCLUSIONS: Avanafil is a potent PDE5 inhibitor and is an effective treatment option for ED. avanafil phosphodiesterase 5A Homo sapiens